Hepatitis B in Pregnant Woman Detected by Triple Elimination Screening in Public Health Centre: A Case Report
Hepatitis B pada Ibu Hamil yang Terdeteksi Melalui Skrining Eliminasi Rangkap Tiga di Puskesmas: Laporan Kasus
Abstract
Introduction: Hepatitis is an inflammation of the liver that can develop into fibrosis (scarring), cirrhosis or liver cancer. As a primary health service facility, the public health centre has an important role in handling Hepatitis B in pregnant women through the Maternal and Child Health program, including triple elimination screening and case management.
Case Presentation: A 23-year-old female patient came to the public health centre for routine antenatal care examination (G1P0A0) with a gestational age of 30 weeks and 4 days. The patient had no complaints (asymptomatic), had a normoweight (20,46) body mass index, and had stable vital signs, normal systemic findings on physical examination and obstetric examination. But when a triple elimination examination was carried out by rapid diagnostic test, the result shown a reactive HBsAg. Then the patient was sent to another public health centre for further advance blood test, and the result shown that the woman was positive for hepatitis B with 2.16E08 IU/mL(log 8.33) viral load. The patient are given 1x300 mg Tenofovir disoproxil fumarate (TDF) treatment along with education by the doctor in charge for Hepatitis division to consume the drug until at least during childbirth, continued until 3 (three) month after delivery.
Conclusion: Identification of pregnant women with Hepatitis B can be early detected by using the triple elimination rapid test (Hepatitis B, Syphilis, HIV) as a mandatory examination for pregnant women. Clinical symptoms for hepatitis B are vary, ranging from asymptomatic to symptomatic such as nausea, vomiting, headache, and malaise, loss of appetite, darker colour of urine, followed by jaundice that appears after 1–2 weeks. However, Hepatitis B in pregnancy is mostly asymptomatic.
Downloads
References
WHO. (2021). Global Health Sector Strategy On Viral Hepatitis 2016-2021.
Bhakti C, Riewpassa C. Hepatitis B Dalam Kehamilan : Laporan Kasus Hepatitis B In Pregnancy: Case Report. Jurnal Medica Profession. 2024 Feb;6(1):18-21.
Kementerian Kesehatan RI. Profil Kesehatan Indonesia 2023. Jakarta: Kemenkes RI; 2023.
Saba C. 2.890 Ibu Hamil di NTT Positif Hepatitis B [Internet]. [cited 2024 Dec 18]. Available from: https://www.rri.co.id/ntt/daerah/300220/2-890-ibu-hamil- di-ntt-positif-hepatitis-b
Ayunda N, Arso S. Pelaksanaan Program Triple Elimination pada Ibu Hamil di Puskesmas Karanganyar Kota Semarang Menggunakan Model CIPP. Media Kesehatan Masyarakat Indonesia. Feb 2023;22(3):210-213.
Kementerian Kesehatan RI. Percontohan Pemberian Antivirus Pada Ibu Hamil Untuk Pencegahan Transmisi Virus Hepatitis B Dari Ibu Ke Anak. Jakarta: Kemenkes RI;2023.
Gozali A. Diagnosis, Tatalaksana, dan Pencegahan Hepatitis B dalam Kehamilan. CKD. 2020;47(5):354-358.
Kementerian Kesehatan RI. Profil Kesehatan Indonesia 2022. Jakarta: Kemenkes RI; 2022.
Denando R, Cahyati W. Faktor Risiko Hepatitis B Pada Ibu Hamil Di Kota Semarang Tahun 2020-2021 (Studi Kasus Di Puskesmas Genuk & Puskesmas Bangetayu). Jurnal Kesehatan Masyarakat. 2022 Nov;10(6):656-659.
Yulia D. Virus Hepatitis B Ditinjau dari Aspek Laboratorium. Jurnal Kesehatan Andalas. 2019;8(4):247-250.
Asafo-Agyei KO, Samant H. Pregnancy and Viral Hepatitis. In: StatPearls[Internet].Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Jan19]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK556026/
Copyright (c) 2025 Cendana Medical Journal

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright Notice
This work is licensed under a Creative Commons Attribution 4.0 International License.